Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Starboard Agreement Tilts Perrigo Toward Rx Generics Sale

Executive Summary

OTC private label giant agrees with Starboard, which owns around 6.7% of Perrigo's shares, to immediately add to Perrigo's board Starboard CEO Jeffrey Smith and two other members recommended by the hedge fund: former Pfizer CEO Jeffrey Kindler and Nestle USA executive Bradley Alford.


Related Content

Perrigo Makes Its Rx Generics Business Look Right At Home
Perrigo Closes Q1 Earnings Saga Trying To Keep Grip On Rx Business
Perrigo Trims Workforce, Ships Tysabri License, Stays European Course
Perrigo Changes Reporting Structure In Latest Stop On Cost-Cutting Trail
Perrigo Puts Tysabri On Block, Generic Topicals Under Microscope
Perrigo's Rx Business Looks Ready To Sell, Says Hedge Fund Investor


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts